Verwandte Artikel zu Vaccines for Pandemic Influenza: 333 (Current Topics...

Vaccines for Pandemic Influenza: 333 (Current Topics in Microbiology and Immunology) - Hardcover

 
9783540921646: Vaccines for Pandemic Influenza: 333 (Current Topics in Microbiology and Immunology)

Inhaltsangabe

Book by Compans Richard W Orenstein Walter A

Die Inhaltsangabe kann sich auf eine andere Ausgabe dieses Titels beziehen.

Reseña del editor

Recent years have seen unprecedented outbreaks of avian influenza A viruses. In particular, highly pathogenic H5N1 viruses have not only resulted in widespread outbreaks in domestic poultry, but have been transmitted to humans, resulting in numerous fatalities. The rapid expansion in their geographic distribution and the possibility that these viruses could acquire the ability to spread from person to person raises the risk that such a virus could cause a global pandemic with high morbidity and mortality. An effective influenza vaccine represents the best approach to prevent and control such an emerging pandemic. However, current influenza vaccines are directed at existing seasonal influenza viruses, which have little or no antigenic relationship to the highly pathogenic H5N1 strains. Concerns about pandemic preparedness have greatly stimulated research activities to develop eff- tive vaccines for pandemic influenza viruses, and to overcome the limitations inh- ent in current approaches to vaccine production and distribution. These limitations include the use of embryonated chicken eggs as the substrate for vaccine prod- tion, which is time-consuming and could involve potential biohazards in growth of new virus strains. Other limitations include the requirement that the current inac- vated influenza vaccines be administered using needles and syringes, requiring trained personnel, which could be a bottleneck when attempting to vaccinate large populations in mass campaigns. In addition, the current inactivated vaccines that are delivered by injection elicit limited protective immunity in the upper respiratory tract where the infection process is initiated.

Reseña del editor

The recent outbreak of disease caused by a novel H1N1 virus has focused global attention on the threat of a new influenza pandemic. Recent years have also seen unprecedented outbreaks of avian influenza A viruses. In particular, highly pathogenic H5N1 viruses have not only resulted in widespread outbreaks in domestic poultry, but have been transmitted to humans resulting in numerous fatalities. The rapid expansion in the geographic distribution of these novel viruses raises the risk that such a virus could cause a global pandemic with high morbidity and mortality. An effective influenza vaccine represents the best approach to prevent and control such an emerging pandemic. However, current influenza vaccines are directed at existing seasonal influenza viruses, which have limited antigenic relationships to the newly emerging virus strains. Concerns about pandemic preparedness have greatly stimulated research activities to develop effective vaccines for pandemic influenza viruses, and to overcome the limitations inherent in current approaches to vaccine production and distribution. These limitations include the use of embryonated chicken eggs as the substrate for vaccine production; which is time-consuming and could involve potential biohazards in growth of new virus strains. Other limitations...more on http://springer.com/978-3-540-92164-6

„Über diesen Titel“ kann sich auf eine andere Ausgabe dieses Titels beziehen.

Gebraucht kaufen

Zustand: Sehr gut
Zustand: Sehr gut - Neubindung,... Mehr zu diesem Angebot erfahren

Versand: EUR 45,00
Von Deutschland nach USA

Versandziele, Kosten & Dauer

In den Warenkorb

Weitere beliebte Ausgaben desselben Titels

9783642242403: Vaccines for Pandemic Influenza: 333 (Current Topics in Microbiology and Immunology)

Vorgestellte Ausgabe

ISBN 10:  3642242405 ISBN 13:  9783642242403
Verlag: Springer, 2011
Softcover

Beste Suchergebnisse beim ZVAB

Beispielbild für diese ISBN

Unbekannt
ISBN 10: 3540921648 ISBN 13: 9783540921646
Gebraucht Hardcover

Anbieter: Buchpark, Trebbin, Deutschland

Verkäuferbewertung 5 von 5 Sternen 5 Sterne, Erfahren Sie mehr über Verkäufer-Bewertungen

Zustand: Sehr gut. Zustand: Sehr gut - Neubindung, Buchschnitt etwas zu weit abgeschnitten, Aufl. 2009 | Seiten: 532 | Sprache: Englisch | Produktart: Bücher. Artikel-Nr. 4914060/12

Verkäufer kontaktieren

Gebraucht kaufen

EUR 210,21
Währung umrechnen
Versand: EUR 45,00
Von Deutschland nach USA
Versandziele, Kosten & Dauer

Anzahl: 1 verfügbar

In den Warenkorb

Foto des Verkäufers

Walter A. Orenstein
ISBN 10: 3540921648 ISBN 13: 9783540921646
Neu Hardcover

Anbieter: AHA-BUCH GmbH, Einbeck, Deutschland

Verkäuferbewertung 5 von 5 Sternen 5 Sterne, Erfahren Sie mehr über Verkäufer-Bewertungen

Buch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - Recent years have seen unprecedented outbreaks of avian influenza A viruses. In particular, highly pathogenic H5N1 viruses have not only resulted in widespread outbreaks in domestic poultry, but have been transmitted to humans, resulting in numerous fatalities. The rapid expansion in their geographic distribution and the possibility that these viruses could acquire the ability to spread from person to person raises the risk that such a virus could cause a global pandemic with high morbidity and mortality. An effective influenza vaccine represents the best approach to prevent and control such an emerging pandemic. However, current influenza vaccines are directed at existing seasonal influenza viruses, which have little or no antigenic relationship to the highly pathogenic H5N1 strains. Concerns about pandemic preparedness have greatly stimulated research activities to develop eff- tive vaccines for pandemic influenza viruses, and to overcome the limitations inh- ent in current approaches to vaccine production and distribution. These limitations include the use of embryonated chicken eggs as the substrate for vaccine prod- tion, which is time-consuming and could involve potential biohazards in growth of new virus strains. Other limitations include the requirement that the current inac- vated influenza vaccines be administered using needles and syringes, requiring trained personnel, which could be a bottleneck when attempting to vaccinate large populations in mass campaigns. In addition, the current inactivated vaccines that are delivered by injection elicit limited protective immunity in the upper respiratory tract where the infection process is initiated. Artikel-Nr. 9783540921646

Verkäufer kontaktieren

Neu kaufen

EUR 320,99
Währung umrechnen
Versand: EUR 32,99
Von Deutschland nach USA
Versandziele, Kosten & Dauer

Anzahl: 1 verfügbar

In den Warenkorb